Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial.
Schmidt M, Victor A, Bratzel D, Boehm D, Cotarelo C, Lebrecht A, Siggelkow W, Hengstler JG, Elsässer A, Gehrmann M, Lehr HA, Koelbl H, von Minckwitz G, Harbeck N, Thomssen C. Schmidt M, et al. Among authors: koelbl h. Ann Oncol. 2009 Feb;20(2):258-64. doi: 10.1093/annonc/mdn590. Epub 2008 Sep 29. Ann Oncol. 2009. PMID: 18824499 Free article. Clinical Trial.
Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.
Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E, Lebrecht A, Siggelkow W, Weikel W, Schiffer-Petry I, Gebhard S, Pilch H, Gehrmann M, Lehr HA, Koelbl H, Hengstler JG, Schuler M. Schmidt M, et al. Among authors: koelbl h. Clin Cancer Res. 2008 Sep 15;14(18):5849-55. doi: 10.1158/1078-0432.CCR-08-0669. Clin Cancer Res. 2008. PMID: 18794096
Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer.
Schmidt M, Petry IB, Böhm D, Lebrecht A, von Törne C, Gebhard S, Gerhold-Ay A, Cotarelo C, Battista M, Schormann W, Freis E, Selinski S, Ickstadt K, Rahnenführer J, Sebastian M, Schuler M, Koelbl H, Gehrmann M, Hengstler JG. Schmidt M, et al. Among authors: koelbl h. Breast Cancer Res Treat. 2011 Feb;125(3):637-46. doi: 10.1007/s10549-010-0856-5. Epub 2010 Mar 30. Breast Cancer Res Treat. 2011. PMID: 20352488
Immunoglobulin kappa C predicts overall survival in node-negative breast cancer.
Chen Z, Gerhold-Ay A, Gebhard S, Boehm D, Solbach C, Lebrecht A, Battista M, Sicking I, Cotarelo C, Cadenas C, Marchan R, Stewart JD, Gehrmann M, Koelbl H, Hengstler JG, Schmidt M. Chen Z, et al. Among authors: koelbl h. PLoS One. 2012;7(9):e44741. doi: 10.1371/journal.pone.0044741. Epub 2012 Sep 28. PLoS One. 2012. PMID: 23028600 Free PMC article.
Adjuvant chemotherapy in early breast cancer.
Schmidt M, Koelbl H. Schmidt M, et al. Among authors: koelbl h. Minerva Ginecol. 2012 Feb;64(1):53-65. Minerva Ginecol. 2012. PMID: 22334231 Review.
Prognostic impact of haemoglobin levels in breast cancer.
Boehm DU, Lebrecht A, Schmidt M, Siggelkow W, Lindner C, Litz A, Ulbrich E, Koelbl H. Boehm DU, et al. Among authors: koelbl h. Anticancer Res. 2007 Mar-Apr;27(2):1223-6. Anticancer Res. 2007. PMID: 17465267 Free article.
209 results